Center for Research on Reproduction and Women's Health

Penn Ovarian Cancer Research Center

Ron Drapkin, MD, PhD, Director
Department of OBGYN
University of Pennsylvania
Biomedical Research Building
421 Curie Blvd., Rm. 1215
Philadelphia, PA 19104

Telephone: 215.746.3973
rdrapkin@mail.med.upenn.edu

Please visit: Drapkin Lab

The Penn Ovarian Cancer Research Center (OCRC), established in 2007, serves as a catalyst to promote comprehensive and interdisciplinary research on ovarian cancer in collaboration with the Jordan Center for Gynecologic Cancer, the Abramson Cancer Center, the Basser Center for BRCA, the Wistar Institute, and the Penn Immunotherapy Program, as well as numerous local, national and international investigators anc clinicans. 

The OCRC has five major goals:

• Develop new methods for early detection of ovarian cancer

• Develop a comprehensive understanding of ovarian cancer pathogenesis

• Characterize the genetic factors that drive the development of hereditary and sporadic forms of ovarian cancer

• Develop new approaches to treat and prevent ovarian cancer

• Support clinical trials to assess safety and efficacy of new treatments

The ultimate goal of these programs is to improve the quality of life for women with ovarian cancer and provide guidance and support to their families.

Faculty

• Robert A.  Burger, MD
• Ron Drapkin, MD, PhD - Director
• Andrea Facciabene, PhD
• Chunseng Li, MD
• Mark A. Morgan, MD
• Daniel J. Powell Jr., PhD
• Fiona Simpkins, MD
• Janos Tanyi, MD
• Lin Zhang, MD